Kaneka Eurogentec
Seraing, BE
Compare mRNA/LNP CDMOs in Europe
Compare Plasmid DNA CDMOs in Europe
Compare Oligo/ASO CDMOs in Europe
Program data pending ClinicalTrials.gov matching
· Last scored 2026-11-02
81.6
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
✓ HC GMP (1)
Quick Facts: Kaneka Eurogentec
- Signal Score
- 81.6/100 (as of 2026-11-02)
- Quality Compliance
- 99.9/100 — Clean EMA record: 4 active GMP certificates (no deductions)
- Headquarters
- Seraing, BE
- Modalities
- mRNA, Plasmid, Oligonucleotide
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Kaneka Eurogentec
European mRNA/pDNA CDMO with GMP capabilities.
Signal Score & Pillar Breakdown
Quality Compliance
99.9
Clean EMA record: 4 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 4 active GMP certificates (no deductions)
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2024-02-26)
EMA GMP Certificates4 on record
Most Recent HC OutcomeCompliant · 2024-02-26
HC Attribution1 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Clean EMA record: 4 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Plasmid, Oligonucleotide
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
68.0
Parent company: Kaneka Corporation (4118.T)
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Kaneka Corporation (4118.T)
Financial assessment: 68.0/100
Capacity
63.0
2 manufacturing sites
Sites: Seraing, Belgium, Fremont, CA, United States
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
2 manufacturing sites
Kaneka Eurogentec FDA Inspection History
2024-02
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2024-02-26 |
Kaneka Eurogentec SA
Seraing
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Kaneka Eurogentec EMA GMP Compliance 4 certificates
2025-03
2024-02
2024-02
2024-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| BE/GMP/2025/009 | Kaneka Eurogentec | Belgium | 2025-03-13 | COMPLIANT |
| BE/GMP/2024/009 | Kaneka EurogentecAlternative Name:Kaneka Eurogentec S.A. | Belgium | 2024-02-26 | COMPLIANT |
| BE/GMP/2024/008 | Kaneka EurogentecAlternative Name:Kaneka Eurogentec S.A. | Belgium | 2024-02-26 | COMPLIANT |
| BE/GMP/2024/010 | Kaneka EurogentecAlternative Name:Kaneka Eurogentec S.A. | Belgium | 2024-02-26 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Japan-accredited overseas site (PMDA)
biologics · 1 site
- Seraing, Belgium · Kaneka Eurogentec S.A. — biologics · valid to Aug 14, 2029
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About Kaneka Eurogentec
How many FDA inspections does Kaneka Eurogentec have on record?
CDMO Signal tracks 1 FDA inspection for Kaneka Eurogentec, sourced from the FDA inspection database. See the full inspection history above.
Has Kaneka Eurogentec received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Kaneka Eurogentec.
Does Kaneka Eurogentec hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for Kaneka Eurogentec.
What is Kaneka Eurogentec's CDMO Signal Score?
Kaneka Eurogentec has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating Kaneka Eurogentec for a manufacturing program?
Use the free AI matchmaker to compare Kaneka Eurogentec against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
Nitto Denko Avecia
Milford, MA
Signal Score: 80.3
Oligonucleotide, mRNA
Aldevron
Fargo, ND
Signal Score: 80.3
Plasmid, mRNA
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
Compare Kaneka Eurogentec with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.